23% were classified as ‘Large’, but these companies accounted for most of the relief claimed (90%).
Over half (52%) of the companies were in the Manufacturing sector (including Pharmaceuticals).
The number of companies claiming relief varies significantly across UK regions, with the highest number in the South East (15%) and the lowest in the North East (2%). There is also significant regional variation in the value of relief claimed, companies in London claimed the largest amount of relief (51%).
Patent Box is equally important and there should be an intrinsic correlation between IP and R&D. £5.3bn was claimed in R&D tax credits in 2018-19 (as of June 2020), but only £992 million had been claimed under the Patent Box scheme.
Businesses are just not leveraging their intellectual property as an asset. GovGrant research shows 83% of SMEs see the importance of commercialising IP, yet only 24% think this is the main point of a patent.
We are not seeing enough new patent applications in this country. This is a huge source of untapped funding for UK SMEs and could hold the key to building back better after Covid-19.